Kestra Medical Technologies Announces Appointment of Veteran Medical Device Executive, Raymond W. Cohen, to its Board of Directors

Kestra Medical Technologies Announces $196 Million Oversubscribed Financing Round

Kestra Medical Technologies Surpasses 200 Million Covered Lives for ASSURE Wearable Cardioverter Defibrillator (WCD) System

Kestra Medical Technologies Offers Electrophysiology and Cardiology Clinicians Opportunity to Wear ASSURE WCD System at #HRX2023 Conference

Kestra Medical Technologies Surpasses 100 Million Covered Lives for ASSURE Wearable Cardioverter Defibrillator (WCD) System

ASSURE Wearable Cardioverter Defibrillator (WCD) System Earns 2022 Medical Design Excellence Award

ASSURE Wearable Cardioverter Defibrillator (WCD) System Demonstrates Low False Alarm Rates, High Patient Compliance in Clinical Study

Kestra Medical Technologies Receives FDA Approval for ASSURE Wearable Cardioverter Defibrillator (WCD)